Speaker illustration

Doctor Troels Yndigegn

Department of Cardiology, Lund (Sweden)

Member of:

European Society of Cardiology

Fibroblast growth factor-23 (FGF23), an early biomarker of sublinical kidney dysfunction, is associated with poor prognosis in acute coronary syndrome patients

Event: ESC Congress 2018

Topic: Biomarkers

Session: Biomarkers in acute coronary syndromes


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb